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ABSTRAK 
Latarbelakang: Osteosarkoma merupakan barah tulang yang paling kerap dikalangan 
pesakit muda. Biopsi adalah cara yang paling baik untuk memastikan diagnosa 
osteosarkoma. Tempat di mana trek dan parut biopsi itu terletak adalah amat mustahak 
kerana parut biopsi itu di bedah dan dikeluarkan bersama barah tersebut semasa 
pembedahan menyelamatkan anggota. Ini adalah selari dengan tanggapan bahawa trek 
biopsi tersebut telah dicemari oleh sel-sel barah. Pengekalan tisu bagi memastikan 
terdapatnya tisu lembut yang cukup, dan pengekalan fungsi anggota masih menjadi 
cabaran kepada pakar bedah onkologi. 
Kajian ini meninjau insiden pencemaran trek biopsi osteosarkoma dengan sel-sel barah 
iaitu di lapisan 'pseudo' kapsul, otot, fascia, lapisan subkut dan kulit. lni adalah untuk 
mengetahui tahap pencemaran bagi membolehkan pembedahan trek dan parut biopsi 
yang selamat. 
Metadologi: Kajian ini merupakan kajian "prospective cross-sectional" dan dijalankan di 
Hospital Universiti Sains Malaysia, Kubang Kerian, di antara bulan Mei 2003 hingga 
Mac 2005. Dua puluh enam kes yang didiagnosa sebagai osteosarkoma dan menjalani 
pembedahan menyelamatkan anggota atau amputasi telah dikaji. Trek-trek biopsi dari 
kes-kes ini di hantar secara keseluruhan untuk diteliti untuk pencemaran sel-sel barah. 
xi 
Keputusan: Daripada dua puluh enam kes yang di analisa, dua puluh satu kes (80.2%) 
tidak menunjukkan sebarang pencemaran sel·sel barah di trek biopsi. Satu kes (3.8%) 
menunjukkan pencemaran sel-sel barah di lapisan 'pseudo' kapsul. Dua kes (7.7%) 
menunjukkan pencemaran sehingga ke lapisan otot dan dua lagi kes (7. 7%) menunjukkan 
pencemaran sehingga ke lapisan tisu subkut. Tiada sebarang pencemaran sel-sel barah di 
lapisan kulit. 
xii 
ABSTRACT 
Background: Osteosarcoma is the most common non-haemopoetic primary bone 
malignancy afflicting the young. Biopsy remains the gold standard in the confirmation of 
the diagnosis. The placement of the biopsy is of utmost importance as the tract is 
removed en bloc with the tumour during limb sparing surgery, with the assumption that it 
is contaminated by the tumour. Tissue conservation, to ensure adequate soft tissue cover, 
and preservation of function still remains a challenge for musculoskeletal oncology 
surgeons. 
This study aims to investigate the incidence of tumour infiltration in osteosarcoma biopsy 
tract, namely in the pseudocapsule, surrounding muscle, fascia, subcutaneous tissue and 
skin; in order to explore the margin of tumour infiltration for safe resection of the biopsy 
scar. 
Materials and methods: This is a prospective cross sectional study, carried out from 
May 2003 to March 2005 at Hospital Universiti Sains Malaysia, Kubang Kerian, 
Kelantan. A total of twenty six cases which had undergone either limb salvage surgery or 
amputation by the Orthopaedic Oncology and Reconstructive Unit, School of Medical 
Sciences, University Science Malaysia, with the histopathological diagnosis of 
osteosarcoma were collected. The biopsy tracts were submitted as a whole and examined 
histologically for tumour presence. 
xiii 
Results: Of the 26 cases examined, twenty one cases (80.8%) did not show any tumour 
infiltration in the biopsy tract. One case (3.8%) had tumour infiltration in the 
pseudocapsule, two cases (7. 7%) had infiltration to the muscle and another two cases 
(7.7%) had infiltration up to the subcutaneous tissue. None had skin infiltration 
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1. INTRODUCTION AND LITERATURE REVIEW 
Musculoskeletal malignant neoplasms, whether primary or secondary, bone or soft tissue 
are now being diagnosed more often as the awareness of its occurrence has increased. A 
high degree of clinical suspicion, earlier access to specialists and the availability of 
imaging modalities have dramatically improved the detection, treatment and outcome of 
these diseases. The progress in radiographic imaging, chemotherapy, radiation therapy, 
nuclear imaging, bioengineering and technology, and genetics has led to an 
understanding of the biological behaviour of mesenchymal neoplasms at a molecular 
level thus, affecting the rationale of diagnosis, staging and treatment. 
Osteosarcoma is the tumour of choice for this study, as it is the most common primary 
malignancy of the bone (20% to 22% ), excluding marrow based malignancies such as 
myeloma, lymphoma and leukaemia (Simon M.A., 1998). In contrast, soft tissue tumours 
are more heterogenous as they arise from various supporting extraskeletal mesenchymal 
tissues and they are rare, constituting less I% of all cancers (Dee R., 1997). 
Osteosarcoma provides the model on which the treatment of all sarcomas is based upon. 
Thus, osteosarcoma provides uniformity for the study and minimizes biasness. 
Subsequent to clinical and radiological evaluations, biopsy is the most significant step in 
the diagnosis of osteosarcoma. In this study, the focus is on the osteosarcoma biopsy 
tract. Among all the musculoskeletal neoplasms, a biopsy performed for osteosarcoma is 
the most challenging, as it has to penetrate deep down to the bone. The biopsy tracts are 
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longer and involve multiple anatomical layers, namely, the skin, subcutaneous tissue, 
muscle and pseudocapsule before reaching the tumour. 
In the past, biopsies were performed through large incisions resulting in significant 
contamination of the surrounding soft tissue with tumour cells. However, the degree of 
contamination had little significance as the treatment for most malignant tumours was 
amputation. (Malawer M.M., 200 I). In contrast, today 90-95% of patients with 
malignant tumours are treated with limb sparing surgery (LSS). (Malawer M.M., 
2001 ). The issue of biopsy tract contamination is significant to the present day treatment. 
The placement of the biopsy, the length of the tract and size of the scar are important 
variables as they determine whether a limb can be salvaged and the amount of soft tissues 
to be sacrificed in LSS. These variables also affect the function of the limb. Biopsies that 
are poorly performed affect the diagnosis, and may lead to amputation of the limb in 
order to achieve an adequate surgical tumour clearance. In planning the definitive 
surgery, the biopsy tract has always been assumed to be contaminated with tumour cells, 
hence it is resected with the same safety margins as the primary tumour. (Malawer M.M., 
2001 ). This leads to increased soft tissue defect and further compromise in limb function 
restoration. 
There are concerns regarding the potential of accelerated growth or metastatic 
dissemination of a malignant tumour after biopsy, but there are no well established 
evidence, although the risk of local recurrence has been reported (Davies N.M. et al., 
1993). 
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The treatment of osteosarcoma, before 1975 consisted mainly of amputation with fewer 
than 20% of patients surviving beyond five years (Sweetnam R. et al., 1971). Majority of 
these patients developed distant metastases within the first 2 years of treatment (Link 
M.P. et al., 1986). The dramatic improvement in survival in the last two decades had 
been mainly contributed by the efficient chemotherapy to combat micro-metastases. The 
modem treatment programme is multimodal in nature. It incorporates neoadjuvant 
chemotherapy, surgery to control local disease and adjuvant treatment. The five-year 
survival rate with multidisciplinary approach varies from 60-70% (Rougraff B. T. et 
a/.,1994). 
This study intends to verify the truth of the assumption that all biopsy tracts are 
infiltrated. It determines the evidence of tumour infiltration in the various layers of 
osteosarcoma biopsy tract. The results of this study could change the subsequent 
management of osteosarcoma. If infiltration is found to be absent then; 
1. The osteosarcoma biopsy tract need not be excised en-bloc during LSS, if the scar 
is not in line with the surgical incision. 
2. Soft tissue resection may be minimized and the indication for free flap can be 
reduced 
3. Osteosarcoma biopsies could be performed in other primary referral centres and 
the diagnoses obtained earlier. 
These will enhance the outcome and decrease the morbidity associated with LSS 
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1.1 OVERVIEW OF MUSCULOSKELETAL TUMOURS 
A neoplasm or tumour is defined as an abnormal mass of tissue, the growth of which 
exceeds and is uncoordinated, with that of the normal tissue, and persists in the same 
excessive manner after the cessation of the stimuli which evoked it. It can either be 
benign or malignant. A carcinoma is a malignant tumour of epithelial origin whereas a 
sarcoma is a malignant tumour of mesenchymal origin. 
Neoplasms of the musculoskeletal system are still less common as compared to 
neoplasms from other systems. Approximately 8000 new cases (6000 soft tissue and 
2000 bone) of sarcoma were reported in America in 1995 (Dee R., 1997). Primary 
musculoskeletal neoplasms whether bone or soft tissue, benign or malignant are generally 
classified based on their histologic type e.g. chondrogenic, osteogenic, fibrogenic, 
notochordal, vascular, lipogenic, haematopoeitic or neurogenic. Malignant tumours are 
differentiated from their benign counterparts by their ability to infiltrate into adjacent 
tissues as well as distant sites to produce another tumour, deemed metastases. In general, 
local behaviour of malignant tumours reflects their more aggressive biological activity 
(Simon M.A., 1998).However some benign mesenchymal tumours such as, giant cell 
tumour, can be locally aggressive but do not metastasize, they rapidly infiltrate local 
tissues and have the local characteristics of a malignant lesion and cannot be 
distinguished from them without a histological examination (Simon M.A., 1998). 
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1.2 OSTEOSARCOMA 
Osteosarcoma is a high grade malignant spindle cell tumour arising within a bone. Its 
distinguishing characteristic is the production of neoplastic osteoid or immature bone, 
directly from a malignant spindle cell stroma. Secondary osteosarcomas are usually 
associated with a pre-existent disease such as Paget's disease, (Hadjipavlov et al., 1992) 
irradiated bones, (Sheppard and Libshitz, 2001) multiple hereditary exostosis, bone 
infarcts, polyostotic fibrous dysplasia, osteogenesis imperfecta, solitary osteochondroma, 
chronic osteomyelitis, nonossifying fibroma, aneurysmal bone cyst, previous metallic 
implant, osteopoikilosis and osteopetrosis. (Simon M.A., 1998). Secondary 
osteosarcomas are rare in people below 21 years (3 %) and the occurrence is about 26% 
in adults above 21 years. However it is rather common in patients above 60 years of age, 
with an incidence of 56%. (Simon M.A., 1998). 
Most osteosarcomas (98% to 99%) are solitary neoplasms but occasionally they may be 
multifocal at similar stages of development. Synchronous osteosarcomas are multifocal 
tumours in which all the skeletal lesions are identified at nearly identical times (within 6 
months of presentation). Metachronous osteosarcomas have longer time interval between 
patient presentation and discovery of the tumour at other sites (greater than 6 months) 
(Simon M.A., 1998). 
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1.2.1 INCIDENCE AND EPIDEMIOLOGY 
Osteosarcoma is the most common primary malignant bone tumour in children and young 
adults comprising about 15% of all primary bone tumours confirmed at biopsy (Dahnert 
W., 2003). In the older age group, osteosarcoma is the second most common primary 
malignant bone tumour after multiple myeloma. 
The worldwide prevalence of osteosarcoma is 4-5:1,000,000. (Dahnert W., 2003). In the 
Mayo clinic series the prevalence of osteosarcoma was 1-3 per million. (Campbell W.C., 
2003). There is no specific data regarding the incidence of osteosarcoma in Malaysia. 
However according to the National Cancer Registry, in 2003, the incidence of bone 
cancer was 0.9 per 100,000 population, and in the state ofKelantan it is 1.3 per 100,000. 
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1.2.2 AGE AND GENDER 
Osteosarcoma is the most common malignant tumour of adolescence, exceeded only by 
leukaemia and lymphoma. (Gibbs eta/., 2001). It occurs at the adolescent growth spurt, 
with the peak incidence between 10 to 20 years of age; 75 percent of all cases occur 
between I 0 to 30 years of age. (Vigorita V .J ., 1999). Males are affected more frequently 
with a male to female ratio of 1.5-2:1. (Campannaci M. et al., 1981 ). 
It is a rare tumour in young children and even rarer in infants. However when it occurs, 
the clinical presentation, radiographic imaging and pathological features are similar to 
those of the affected age group. (Kazakewich et al., 1991). 
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1.2.3 ANATOMIC DISTRIBUTION OF OSTEOSARCOMA 
Osteosarcoma may arise in any skeletal site with the majority of them arising from the 
metaphyses of long bones. Fifty six percent of all osteosarcomas occur at the knee 
resulting in it being the most common primary osseous knee tumour reported in literature. 
(Vigorita V.J., 1999). Of this figure, 64% occur in the distal femur, 32% in the proximal 
tibia, about 4% in the proximal fibula and less than 1% in the patella. (Figure 1.1) 
Osteosarcoma is rare in the spine, pelvis, skull and fibula and the other flat bones in the 
body (Simon M.A., 1998). 
Osteosarcoma predominantly arises from the metaphysis (80 to 90%) and followed by the 
diaphysis (1 0 to 20%) and the epiphysis ( <1% ). (Simon M.A., 1998). 
3o/o .. 
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Figure 1.1: Skeletal Distribution Of Osteosarcoma 
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Extraskeletal osteosarcoma is located within the soft tissue, without attachment to the 
bone or periosteum. Extraskeletal osteosarcomas contribute 4% to the incidence of all 
osteosarcomas and constitute 1% of all soft tissue sarcomas. (Dahnert W ., 2003). 
Anatomically, they may arise anywhere, with the thigh, upper extremity including the 
shoulder girdle and retroperitoneum being the most common locations. (Vigorita V.J., 
1999). The mean age of presentation is 50 years with 94% of patients presenting after 
the age of 30. (Dahnert W., 2003). They present as painful or painless masses in various 
sizes and consistencies. 
X -rays may reveal different levels of mineralization without bony involvement. 
Magnetic Resonance Imaging (MRI ) demonstrates a well demarcated non homogenous 
soft tissue mass with a mixed Tl weighted signal and is hyperintense on T2 weighted 
images. Bone scans show hot spots, reflecting the vascularity and mineralization activity 
of the tumour. Microscopically they are similar to osteosarcoma predominantly 
osteoblastic to fibroblastic, malignant fibrous histiocytoma (MFH) like and giant-cell 
rich. (Vigorita V .J ., 1999). 
Extraskeletal osteosarcoma have a high chance of local recurrence, approximately 50% 
and metastasise 62% of the time. (Vigorita V .J ., 1999). Lee et al. reported a 5 year 
survival rate of 3 7 %. The lungs, bone and soft tissue are the most frequent sites for 
metastases. (Vigorita V .J ., 1999). 
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1.2.4 CLINICAL PRESENTATION 
Pain is the most common complaint on presentation, occurring in 85% of patients. 
However it occurs late relative to the disease process itself, as the pain is due to tumour 
expansion into surrounding tissues associated with local bone destruction and cortical 
erosion. (Malawer M.M., 1992). Presence of a firm soft tissue mass fixed to the 
underlying bone is found on physical examination. Local inflammatory signs, venous 
stasis and engorgement with decreased range of motion of the adjacent joints are found in 
advanced tumours. 
Presentation with a pathological fracture occurs in less than 1% of patients with 
osteosarcoma. (Malawer M.M., 1992).Systemic symptoms are rare unless associated with 
late complications of pulmonary metastases (Dee R., 1997). As most osteosarcomas are 
high grade, development of metastases occurs early in the disease. Link et a/. described 
that 80% of patients will have microscopic spread of tumour at the time of diagnosis. 
Like other sarcomas, osteosarcoma spreads is via hematogenous route and 90% is to the 
lungs. (Simon M.A., 1998). 
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1.2.5 IMAGING 
The distinctive features of osteosarcoma on plain radiography are medullary and cortical 
bone destruction, an aggressive periosteal reaction, a soft tissue mass, and tumour bone 
either within the destructive lesion or at its periphery. The most common types of 
periosteal reaction encountered in osteosarcoma are the "sunburst" type and Codman' s 
triangle. The lamellated or onion skin type of reaction is less frequently seen. (Greenspan 
A., 2000). Osteosarcoma lesions may present as purely sclerotic in about 45% of cases, 
purely osteolytic in 30% or a combination of both, in 25% of cases. (Forest M., 1988). 
The tumour borders are indistinct with a wide zone of transition. The type of bone 
destruction is either moth-eaten or permeative, rarely geographical. In some cases, the 
type of bone destruction may not be obvious on plain radiographs but patchy densities 
representing tumour bone and an aggressive periosteal reaction should help lead to the 
diagnosis. 
Magnetic resonance imaging (MRI) is the preferred modality and has become the current 
standard technique for evaluating these tumours, in particular for intraosseous tumour 
extension and soft tissue involvement (Gillepsy et al., 1998). MRI is superior in detecting 
skip lesions and transphyseal spread which occurs in 70-80% of cases (Norton et al., 
1991 ). On MRI, the tumour is of intermediate signal intensity on Tl weighted images 
(Tl WI) and high signal intensity on T2 weighted images (T2WI). Marrow extension is 
clearly defined and best appreciated on Tl WI images. Both neurovascular and soft tissue 
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involvement are delineated with the latter best demonstrated on T2WI images. (Dahnert 
w., 2003). 
Before the advent of MRI, Computer Tomography (CT) was the modality of choice for 
staging osteosarcoma. It is highly accurate for determining the extent of bone 
involvement because there is high contrast between tumour and fatty marrow. However 
CT is inferior to MRI in defining muscular involvement and delineating the 
neurovascular structures. (Simon M.A., 1998). Currently, CT is useful in detecting 
pulmonary metastases which is the most common site for metastases. 
Bone scintigraphy has an important role in tumour staging. It establishes areas of primary 
involvement, local extent, skip metastases and sites of synchronous metastases. The 
tumour shows intense increased activity on blood flow, blood pool and delayed images, 
indicating hypervascularity and the presence of new bone formation. (Dahnert W., 2003). 
The extent of involvement may easily be overestimated on bone scans due to the intensity 
of uptake by the tumour, and must be correlated with the findings on other imaging 
modalities. 
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1.2.6 BIOLOGICAL BEHAVIOUR OF THE TUMOUR 
Sarcomas in general, form a solid mass that grow centrifugally with the periphery of the 
lesion being the least mature and is enclosed by a reactive zone or pseudocapsule. 
Pseudocapsule is an area composed of compressed tumour cells and a fibrovascular 
network of variable inflammatory components that interacts with surrounding normal 
tissue. Lesions within the pseudocapsule are known as "satellite nodules". High grade 
sarcomas have a poorly defined pseudocapsule which may be locally invaded by the 
tumour. 
Osteosarcomasas respect anatomical barriers and take the path of least resistance during 
growth in the earlier stages. In the later stages, the walls of the compartment i.e. bone 
cortex or aponeurosis of a muscle, is violated and the tumour breaks into the surrounding 
compartments. At the time of presentation, most osteosarcomas are extracompartmental 
(Malawer M.M., 200 I), they destroy the overlying cortex and extend directly into the 
surrounding soft tissue. The anatomical barrier is important in delineating the surgical 
margin. In the immature skeleton with an intact growth plate, the epiphysis may act as a 
relative barrier to its growth. However in more than half the cases, epiphyseal extension 
is massive, with the plate being partially or completely crossed and the tumour abutting 
against the articular cartilage. The articular cartilage is an anatomical barrier and is rarely 
invaded by the tumour. This phenomenon allows intrarticular resection of osteosarcomas 
(Simon and Bos, 1980). Invasion of the joints may occur in 19-24% of cases and there is 
no corelation with tumour size, except for very large tumours. (Vigorita V .J ., 1999). 
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Thick fascial planes and aponeuroses are barriers to tumour extension. In the thigh, the 
lateral intermuscular septum acts as an anatomical barrier to tumours arising from the 
anterior compartment to the hamstrings. 
"Skip metastases" within the same anatomic compartment is formed by the breakage 
through the pseudocapsule. They are solitary, separate tumour foci, not in continuity with 
the main tumour mass, occurring synchronously without pulmonary metastases, with an 
incidence up to 19% in one series (Enneking and Kagan, 1975).The occurrence of local 
recurrence, inspite of an adequate surgical resection is attributed to skip lesions. 
(Malawer M.M., 200 I). 
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1.2.7 PATHOLOGY OF OSTEOSARCOMA 
The pathology of osteosarcoma incorporates both the gross pathology as well as the 
detailed histopathology. The hallmark in diagnosing osteosarcoma is by histologic 
examination of biopsied tissue.(Vigorita V .J ., 1999). 
1.2.7.1 GROSS PATHOLOGY 
On gross appearance osteosarcoma is a hard, compact tumour which appears as a yellow-
white dense, sclerotic and calcified mass. Usually the tumour originates from the 
medullary canal, penetrates the cortex, raises the periosteoum and invades the soft tissue. 
Although predominantly it is osteoblastic there may be a fibrous or cartilaginous foci. 
The fibrous component appears gray-white and the tumoural cartilage is generally blue-
gray. Bone necrosis, hemorrhage and cystic degeneration are common. Undifferentiated 
tumours are soft and fleshy. (Forest M., 1988). The pseudocapsule is frequently seen 
enveloping the soft tissue component at the periphery of the osteosarcoma. (Vi go rita V .J ., 
1999). 
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1.2.7.2 IDSTOPATHOLOGY 
Histopathologically, osteogenic sarcoma is characterized by the presence of sarcomatous 
osteoblast cells producing a disorganized maze of calcified tissue including osteoid and 
bone (Vigorita V .J ., 1999). Masses of osteoid without accompanying groups of cells is 
highly suspicious foe osteosarcoma. As with other bone and soft tissue neoplasms, 
osteosarcoma has a characteristic pattern of biological behaviour which is the basis of 
grading. Histologically it is graded as low ( eg.parosteal), intermediate ( eg.periosteal) or 
high grade (conventional intramedullary). This grading system is based on tumour 
morphology, extent of pleomorphism, cellular atypia, mitosis and necrosis. The grades 
represent the biological aggressiveness of the tumour and correlates with the likelihood of 
metastases. 
Dahlin in 1977 established the histologic classification separating osteoblastic, 
chondroblastic and fibroblastic types. In osteoblastic type, tumoural osteoid appear as a 
fme lacelike network with interlacing network. The chondroid component of the 
chondroblastic osteosarcoma may appear as scattered foci or as a predominantly 
cartilaginous matrix with a malignant appearance. The fibroblastic osteosarcoma may 
mimic fibrosarcoma .(Forest M., 1988). Although all the above variants have 
histologically different predominating cells, there is no mention on the difference in the 
management or the prognosis. 
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The Broder's system is a histologic classification established by Dahlin and Unni (1977, 
revised 1984). According to this system the numerical grade indicates the degree of 
malignancy with grade 1 indicating the least undifferentiated tumour and grade 4 the 
most undifferentiated tumour (Table 1.1). For example, parosteal osteosarcomas are 
regarded as grade 1, periosteal osteosarcomas as grade 2, conventional osteosarcomas as 
grade 3 or 4 and telangiectatic osteosarcomas, pagetic osteosarcomas, multifocal 
osteosarcoma and post irradiation osteosarcomas as grade 4 (Greenspan A., 2000). 
This grading has clinical, therapeutic and prognostic importance. Pulmonary metastases 
is commonly seen in the high grade osteosarcoma (Greenspan A., 2000).This system is 
also incorporated in the Enneking staging system described later. 
Mirra in 1989 stated that 75% of osteosarcomas demonstrate sufficient anaplastic 
changes to establish a diagnosis, but the remaining 25% have a confusing histological 
picture that needed to be correlated clinically and radiologically for diagnosis. For the 
diagnosis of osteosarcoma, identification of tumour bone production and distinguishing it 
from reactive bone formation associated with callus or periosteal response, as well as the 
deposition of chondroid matrix, collagen and fibrin is important as they may mimic 
tumour osteoid. (Simon M.A., 1998). 
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Table 1.1: Histologic Grading Of Osteosarcoma (according to Unni KK., 
Dahlin DC 1984) 
GRADE IDSTOLOGIC FEATURES 
Cellularity: slightly increased 
1 Cytologic atypia: minimal to slight 
Mitotic activity: low 
Osteoid matrix: regular 
Cellularity: moderate 
2 Cytologic atypia: mild to moderate 
Mitotic activity: low to moderate 
Osteoid matrix: regular 
Cellularity: increased 
3 Cytologic atypia: moderate to marked 
Mitotic activity: moderate to high 
Osteoid matrix: irregular 
Cellularity: markedly increased 
4 Cytologic atypia: markedly pleomorphic cells 
Mitotic activity: high 
Osteoid matrix: irregular, abundant 
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1.2.8 STAGING 
Staging is a process of classifying a malignant tumour by taking into account its degree 
of differentiation and its local and distant extent in order to determine the type of 
treatment necessary as well as to estimate the prognosis. It is based on the clinical 
findings, radiological features and the histopathological diagnosis. For sarcomas of the 
bone, there are two systems, one developed by Enneking (Table 1.2) and the other by 
American Joint Committee on Cancer (AJCC). (Table 1.3). Both use the same prognostic 
variables except that the Enneking system groups involvement of regional lymph nodes 
and distant metastases into a single group. 
Enneking's classical staging for musculoskeletal sarcomas is based on 3 factors: 
histological grade (G), anatomical site (T) and the presence or absence of metastases (M). 
(Enneking et a/.1980). (Table 1.2). 
With regards to the histological grading, G, low grade lesions, G 1, correspond to 
Broder's 1 and/or 2, and have a low risk for metastases, less than 25% risk (Simon M.A., 
1998). High grade lesions, G2, which correspond to Broder's 3 and 4 have a significant 
higher incidence of metastases. 
The anatomical site of the lesion is subdivided into intracompartmental (T 1) or 
extracompartmental (T2). Extracompartmental tumours are those that have extended 
beyond the natural barriers either by growth or contamination (via biopsy) and may 
indicate the invasiveness of the tumour. Smaller intracompartmental tumours are further 
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in proximity to the vital neurovascular structures and allow a wider surgical margin of 
normal soft tissue and a greater probability of local control. 
The third factor, presence or absence of metastases relates to the prognosis. 
Hematogenous spread to the lungs and regional metastases to the lymph nodes, the 
former being more common, have the same ominous prognostic significance. Both 
indicate little chance for prolonged survival. (Enneking eta/., 1980) 
Table 1.2: Enneking system for staging of musculoskeletal sarcomas 
STAGE GRADE SITE METASTASES 
lA Low Intracompartmental None 
IB Low Extracompartmental None 
IIA High Intracompartmental None 
liB High Extracompartmental None 
III Any Any Regional or distant 
metastases 
Table 1.3: AJCC system for staging ofbone sarcomas 
GRADE PRIMARY REGIONAL DISTANT 
TUMOUR NODES METASTASES 
lA Low Within cortex None None 
IB Low Beyond cortex None None 
IIA High Within cortex None None 
liB High Beyond cortex None None 
III (not defmed) 
IVA Any Any Present None 
IVB Any Any Any Present 
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1.2.9 TREATMENT 
The goal of treatment in patients with osteosarcoma is to make them disease free and to 
preserve as much function of the limb as possible. In advanced cases, treatment is aimed 
at minimising pain and improving the quality of life. The dramatic improvement in 
survival in the last two decades is mainly attributed to the combination of efficient 
chemotherapy for control of micrometastases at diagnosis, followed by surgery for local 
control of disease and adjuvant chemotherapy. 
In the era where chemotherapy was not routinely used for osteosarcoma, immediate wide 
or radical amputation was performed. It was observed that although local control of 
disease was adequate, 80% of patients eventually died of metastases even though 
metastases was absent at presentation, leading to the inference that these patients had 
micrometases at presentation. (Sweetnam R. et al., 1971). With the advent of modem 
chemotherapy protocols combined with surgery, the current 5-year survival rate is 
approximately 70%. Two year survival rate of 54% with a median follow-up of 24 
months was obtained in a study conducted in this centre. (Fa ish am W .I. e t a 1. , 
2004) 
Adjuvant chemotherapy refers to chemotherapy administered postoperatively to treat the 
presumed micrometastases. Neoadjuvant chemotherapy refers to chemotherapy 
administered before surgical resection of the primary tumour. It presumably decreases the 
spread of tumour cells at the time of surgery, and can be started immediately, thus 
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effectively treating micrometstases at the earliest time possible. It also avoids tumour 
progression in cases of delay in surgery. Neoadjuvant chemotherapy administered, 
followed by surgical resection allows for histological evaluation of the resected specimen 
for the effectiveness of the treatment. The percentage of tumour necrosis is determined 
according to the Huvos grading system ( Huvos and Rosen ., 1987). Patients who are poor 
chemotherapy responders, who have less than 90% tumour necrosis, could be subjected 
to an altered adjuvant chemotherapy regime. The definitive surgical procedure is 
performed 3 to 4 weeks after the last dose of neoadjuvant chemotherapy has been 
administered. Adjuvant chemotherapy is then restarted two weeks post operatively after 
the wound has healed. (Campbell W.C., 2003). 
There are two kinds of protocols for adjuvant chemotherapy followed in different parts of 
the world. The American and the Italian groups prefer to use the more complicated, high 
dose intensive methotrexate based regime (Bacci G., et al., 1993). On the contrary, 
European centres follow simple two drug regime with a combination of cisplatinum and 
adriamycin (Bramwell V .H., et al., 1992). The outcome of dose intense regimen versus 
European Osteosarcoma Intergroup protocol was similar (Souhami R.L. et al., 1997). In 
this centre, due to poor patient compliance and intolerance to the high doses in the 
intensive methotrexate regime, the European protocol is used, which is easy to administer 
and is reproducible. 
Amputation was the mode of treatment for osteosarcoma previously. Today, more than 
90% of patients with osteosarcoma undergo limb sparing procedures at major centers 
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specializing in musculoskeletal oncology. (Malawer M.M., 2001). Advances in 
diagnostic imaging, adjuvant and neoadjuvant chemotherapy, surgical reconstructive 
techniques and the development of a reliable, stable modular prosthesis for reconstruction 
of the hip, shoulder and knee have contributed greatly to the success of LSS. A study 
done at this centre proved that LSS did not compromise survival when compared to 
amputation (Faisham W.l. eta/., 2004).This results of this study was comparable to other 
studies around this region (Chang H.C. et al., 2002). For osteosarcoma of the distal 
femur, the rate of local recurrence after wide resection and limb salvage is approximately 
5% to 1 0% which is comparable to transfemoral amputation, provided a wide surgical 
margin is obtained. (Campbell W.C., 2003). LSS however is associated with greater 
perioperative and long term morbidity as compared to amputation. The surgical 
procedure is more extensive with greater risks for infection, wound dehiscence, flap 
necrosis, blood loss and deep venous thrombosis. Depending on the type of 
reconstruction, the long term complications include periprosthetic fractures, prosthetic 
loosening or dislocation, nonunion of the graft-host junction, allograft fracture, leg length 
discrepancy and late infection. 
The choice between LSS and amputation must be made on the basis of the expectation 
and desires of the individual patient and family. When LSS is chosen, the outcome has to 
be equal or superior to amputation with regards to function and psychosocial benefit to 
the patient. The survival after LSS, and the immediate and delayed morbidity for each 
type of reconstruction has to be considered. (Simon M.A., 1998). 
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Successful limb salvage procedures consist of three surgical phases: (Dee R., 1997). 
1. Resection of the tumour; This strictly follows the principles of oncologic surgery. 
A voiding local recurrence is the main criterion of success and determines the 
amount of bone and soft tissue that has to be removed. 
2. Skeletal reconstruction; The average skeletal defect following adequate tumour 
resection is 15-20 em. Techniques of reconstruction are many. They include 
prosthetic replacement, arthrodesis, allograft or various combinations. These vary 
and are independent of the resection. 
3. Soft tissue and muscle transfer; Muscle transfers are to cover the resection site 
and to restore motor power. Adequate skin and muscle coverage is necessary to 
decrease postoperative morbidity. Distal tissue transfers are not used due to the 
possibility of contamination. 
The surgical guidelines and techniques of limb salvage surgeries are rather strict but vary 
from patient to patient. In general, the major neurovascular bundle must be free of 
tumour. Wide resection of the affected bone must be performed, with a normal tissue cuff 
in all directions. The standard practice is to excise en bloc all previous biopsy sites and 
potentially contaminated tissues. Bone resection is done 3 to 4 em beyond the abnormal 
bone (based on MRI delineation) as to avoid intraosseous tumour extension. (Dee R., 
1997). The relative contraindications to limb salvage surgery are involvement of major 
neurovascular bundle, the presence of pathological fractures, inappropriate biopsy sites, 
infection, immature skeletal age and extensive muscle involvement. The presence of 
pathological fractures increases the risk of local recurrence, but neoadjuvant 
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